FDA Issues Fast Track Designation to First-In-Class Trispecific Antibody for Refractory Multiple Myeloma

Medistri 2024 Carbon Emissions Report: Strengthening Operational Sustainability

HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases

The Vanguard Accelerator welcomes DigeHealth

Onward Therapeutics Receives IMPD to Initiate Phase 1 Clinical Trial of OT-C001

World first test for a visually impaired person on the Transports Lausannois network

Pilatus Biosciences Publishes Preclinical Data in Cancer Discovery on PLT012 First-in-Class CD36-Targeting Antibody for Liver Cancer

Parithera Launches Groundbreaking Platform to Detect and Analyze Circulating Tumor Cells, Pioneering Next-Generation Precision Oncology

Eva.J Swiss Organic Neurocosmetics: Pioneers in Neurocosmetic Skincare

Cellestia Biotech And Tvm Capital Life Science Announce Creation Of Anciata Therapeutics To Develop A First-In-Class Therapeutic Targeting Autoimmune Disorders

Impli wins the Digital Health & Medical Devices track of the 2025 Hello Tomorrow Global Challenge

Novigenix awarded EUR 1.8M in the groundbreaking BRECISE IHI Consortium to industrialize AI-powered liquid biopsy for prediction of immunotherapy response

Cell therapy manufacturing expert, Dr. Jonathan Esensten, joins Limula’s Strategic Advisory Board

Perivision receives CHF300’000 FIT Tech Growth loan

HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer

The Vanguard Accelerator Welcomes Virtuosis

New study reveals novel multi-omics approach with unprecedented treatment response prediction in metastatic urothelial cancer

Limula unveils LimONE: a breakthrough in end-to-end cell therapy manufacturing

Volv Global Expands Office Footprint to Power Next-Generation AI Innovation in Healthcare

BioLizard Awarded Grant from VLAIO to Advance AI-Powered Biomedical Solution for Accelerated Drug Development

Le cAH reprend la marque de l’école La Mandorle (NE) et la gestion de ses formations

Aspivix raises over 2.5 million euros via crowdfunding campaign

42 COMPANIES ARE AWARDED THE SCALE-UP VAUD 2025 LABEL BY INNOVAUD

Neuria within the six start-ups selected for Future of Health Grant

Vitruvian Shield releases new AI-powered health assistant on their app

Demetra Holding Spa acquires majority stake in Swiss-based GetSet Surgical, expanding strategic portfolio in the Spine sector

Le CHUV parmis les “World’s Best Hospitals 2025”

Unisanté regroupe ses activités et rejoint le Biopôle

Neuria receives the “Coup de Pouce” Prize from the Dr. Liechti Foundation

Opna Bio Receives Orphan Drug Designation for OPN-6602, an Oral EP300/CBP Bromodomain Inhibitor, for Multiple Myeloma

biped ai awarded FIT Digital support

Five companies supported by the Biopôle Start-up Fund in 2024

Voltiris Secures CHF 4.8 Million Seed Financing to Power and Electrify High-Tech Greenhouses

Vandria announces first subjects dosed in its first-in-human Phase 1 clinical trial of VNA-318 brain-penetrant mitophagy inducer

Medistri Expands Operations to Hungary, Enhancing Global Healthcare Solutions

25 companies joined Biopôle in 2024

Biopôle-based companies raised over CHF 246m in 2024

Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles

ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma

NewBiologix expands to US, targets growing CGT market

Vandria announces first subjects dosed in its first-in-human phase 1 clinical trial of VNA-318 brain-penetrant mitophagy inducer

Neuria obtains the CHF 150,000 Kick to address overweight treatment with Neuroscience-Powered Digital Health Solution

Limula receives a CHF 500,000 Tech Growth loan from FIT

Pilatus Biosciences Inc. Secures FDA Orphan Drug Designation for PLT012: A Breakthrough in Liver and Intrahepatic Bile Duct Cancer Treatment

Leman Biotech Adds Relapsed or Refractory Indolent B-cell non-Hodgkin Lymphoma to the Clinical Applications and Indications for Meta 10-19 Injection

Opna Bio Announces Interim Data from Phase 1 Combination Study of OPN-2853 with Ruxolitinib in Patients with Advanced Myelofibrosis

Novostia Receives ISO 13485 Certification of its Quality Management System

Ichnos Glenmark Innovation Shares Promising Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, for Patients with Heavily Pretreated Multiple Myeloma

Alithea Genomics Launches Full-Length DRUG-Seq to Unlock Full Power of Transcriptomics for Drug Discovery

Distalmotion Announces First Patients Treated in U.S. with Dexter in the Outpatient Setting

Leman Biotech Initiates IIT Clinical Trial of Meta 10-19 Injection for the Treatment of Moderate to Severe Active Systemic Lupus Erythematosus (SLE)

Biopôle SA et la Caisse de pensions de l’État de Vaud (CPEV) inaugurent le bâtiment Leucine

Gondola Medical and Precise health receive Dongsheng cup’s excellence award

Vanarix Achieves Milestone in Regenerative Medicine with Successful Allogeneic Cartibead Transplantation

Medistri Launches MyMedistri – A Next-Generation Order Management Platform

The SDSC Establishes Permanent Presence at Biopôle with Support from Canton Vaud

Atinary Launching its Self-driving Data Factory: The AI-driven Laboratory for High-Quality Data and Molecules Generation

Médecines alternatives et complémentaires en pleine mutation : l’urgence de se conformer à la réglementation fédérale

Carevix by ASPIVIX Named to TIME’s 2024 Best Inventions List

Perivision obtains CE-marking to commercialize VR- & AI-based eye testing platform VisionOne across EU

FDA Grants De Novo Marketing Authorization for the Distalmotion Dexter Surgical Robot

Impli partners with Bayer to advance its hormone monitoring device

Genknowme announces a new collaboration with Therme Zurzach for a personalised health & wellness experience.

SNH Foundation wins the “Prix Action” from the Ligue Vaudoise contre les Maladies Cardiovasculaires

Gnubiotics Secures Key Composition of Matter Patents for Obesity, Diabetes, and Immune-Related Diseases, Strengthening Its Glycopeptide Therapeutics Platform

PeriVision, Inselspital and the University of Bern receive CHF 1.1M grant to develop new fixation-independent perimetry for retinal diseases

Atinary Technologies Announces Strategic Collaboration with Snapdragon Chemistry, a Cambrex company

Novigenix-led project receives €1.75M grant to improve patient outcomes using liquid biopsy technology

FIT : Nexco Analytic se voit récompensé d’un prêt Tech Seed de 100’000 CHF

Aspivix and Tia Partner to Enhance IUD procedures with Carevix™ across the USA

Novostia Announces New CEO Appointment and Secures Additional CHF 5.6 million in Funding

Swiss surgical robot manufacturer obtains fresh capital

Novigenix unveils multimodal liquid biopsy approach at ESMO 2024, advancing precision medicine with AI-powered immune profiling

Limula highlighted amongst the ‘Frontrunners in automated Cell and Gene Therapy manufacturing’

Novigenix receives ISO 13485 Certification from BSI

Serge Aymon joins Biopôle SA’s Board of Directors

Evidone and SFITS Collaborate to Transform Hospital and Operating Room Operations

HAYA Therapeutics Announces Collaboration with Lilly to Discover Novel Regulatory Genome Targets for Obesity and Related Metabolic Conditions Using Proprietary RNA Platform

Aspivix Announces MHRA Approval for Carevix™

Biopôle SA announces collaboration with reCIRCLE

Exogems Secures CHF 500K in Seed-Stage Financing from Business Angels to Advance Therapeutic Exosome Development

biped.ai recognized by EU-Startups 10 promising European startups helping the blind and visually impaired

Amélie Béduer of Volumina Medical has been nominated finalist in the EY Entrepreneur Of The Year 2024

Genknowme : l’épigénétique vient en renfort des mesures de prévention (24 heures)

SVC Nominates Medistri as One of the Top 5 PME Finalists in Suisse Romande

Testmate Health selected by EU-Startups for leveraging the power of urine for innovative and practical solutions

Vandria secures $30.7M in Series A funding to advance groundbreaking mitophagy therapies

PeriVision partners with distributor Von Hoff to serve Swiss & Liechtenstein markets

NOA by biped marks successful market entry in Europe and the US

HAYA Therapeutics Appoints Former Roche Global Head of Operations Eric Adam, Ph.D. as Chief Operating Officer

Vanarix raised CHF 4 Million to begin new clinical trials

AKYmed: Qualisperm now available as a service

Many successes completed in 2024 by Vanarix

HAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award

Biopôle partners with SHS to broaden the scope of its Vanguard Accelerator

Novostia Announces Successful Implantation of the 10th patient with the TRIFLO Heart Valve

Dandelion Science and the Wyss Center Geneva announce AI partnership to generate non-invasive brain therapies

AKYmed Partners with Rara Avis Biotec to Revolutionize Animal Reproduction Solutions

Aspivix: winner of the 15th French American Entrepreneurship Award

Milestone: 100,000+ Optimizations By SDLabs

Limula raises $6.8M to democratise access to live-saving Cell and Gene Therapies with Swiss-made manufacturing platform

Distalmotion Celebrates Milestone: Over 1000 Procedures Successfully Completed with the Surgical Robot Dexter®

The first successful IUD and transcervical procedures performed with the non-traumatic Carevix™ in Indiana, U.S., enhancing Women’s Care in gynecology

Testmate Health Raises $6M To Launch First At-Home Rapid Test For STIs

ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants

biped.ai wins the Startup Champions Seed Night 2024

NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries

PDC Therapeutics Co-Founder Prof. Rana Sanyal won the European Prize for Women Innovators

BioLizard appoints Matthew Hall as Director of business development

ASPIVIX and Bayer (Schweiz) AG collaborate to reduce pain in Women’s Health procedures

Opna Bio presents promising preclinical data in multiple myeloma

BioLizard and AbnomX announce partnership

Volumina Medical secures USD 21 Million Funding to continue its Clinical Program after having obtained promising First in Human Data

Limula and SR-Tiget partner to deploy a novel bioreactor

Alithea Genomics announces the successful closure of their Seed Financing Extension

PeriVision registers VR- & AI-based eye testing platform VisionOne with US FDA

Gnubiotics Sciences SA has a new scientific advisory board member

The Vanguard Accelerator Welcomes Neuria

Swiss Nutrition and Health foundation is part of a winning EU consortium tackling the complex issue of micronutrient deficiency in Europe

Biopôle receives Plus* certification from the Nature and Economy Foundation

Orbis Medicines Launches with €26 Million Seed Financing

NewBiologix Licenses Florabio’s HEK293 Cell Line for the Generation of Novel and Proprietary Cell Lines for the Stable Expression of rAAVs used in Gene Therapy

Argá Medtech SA closes Oversubscribed Series B

Agora Care reaches a new milestone with 10 000 patients

Abionic Appoints Patrick Pestalozzi as New CEO to Propel Company into Next Growth Phase

PeriVision & Roche explore new use case for tele-ophthalmology concepts

Atinary and Takeda collaborate to drive innovation in healthcare

5 Biopôle members in the new cohort of LeadiNNG to Scale-Up 2024

New Strategic Advisor at Agora Care

AC BioScience achieves breakthrough in colorectal cancer treatment and appoints new CSO

BioLizard announces the appointment of André van de Sande as Chairman of the Board

Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance – ‘Ichnos Glenmark Innovation’

Tigen signs option agreement with leading cancer center for autologous CD371 armored Chimeric Antigen Receptor (CAR) T-cell Technology to advance the therapy development for relapsed/refractory Acute Myeloid Leukemia (AML).

BioLizard announces Swiss subsidiary and service offering for AI-powered digital transformation of life sciences at Biopôle in Lausanne

Novostia Celebrates Successful Implantations of TRIFLO Heart Valve in First Human Patient

Revolutionizing drug development: Novigenix unveils AI-powered RNA analysis for immune response profiling

Distalmotion in Europe’s 10 fastest-growing robotics startup teams

Cellestia awarded Innosuisse Grant to advance a groundbreaking Graft versus Host Disease prevention therapy

Distalmotion Partners With Proximie to Extend Surgical Excellence Globally

Supercharging CAR-T Cells for Cancer Treatment

BD joins Biopôle’s Corporate Partnership Programme

Hycann Health launches medical cannabis distribution operations on the campus of Biopôle, in Lausanne, Switzerland 

Combating over-prescription of antibiotics in children: a digital health innovation with promising results

CE Mark approval paves the way for Aspivix global commercialisation

SIB and Lunaphore secure Innosuisse funding for AI-based assay development tools

Genknowme and Resistell among the 28 Swiss start-ups entering the phase 1 of Innosuisse’s Scale-up Coaching

Industry Leader Greg Roche Joins Distalmotion as CEO

Biopôle’s Vanguard Accelerator welcomes HoliYou

Swiss Startup biped.ai Secures 1.2 Million CHF in Funding to Revolutionize Mobility for the Visually Impaired

Ichnos Sciences Announces Initiation of First-In-Human Clinical Trial for ISB 2001

Leman Biotech and Ucello Therapeutics enter into Comprehensive Strategic Collaboration to Advance Universal CAR-T Development

Leman Biotech and Hangzhou Neoantigen Announce Strategic Collaboration for Developing Neoantigen Cancer Vaccines

Cara collabore avec Pulse Medica pour faciliter l’accès au DEP par les services ambulatoires

LASCCO and Abionic Announce a Licensing Agreement with Fapon for PSP Sepsis Diagnosis in China

Biopôle and Catalyze4Life EPFL join forces

Hedera Dx Launches Blood Based Cancer Testing That Allows Larger Patient Populations to Access Cancer Therapies

BioTools Innovator Names Limula 2023 Winner

Leman Biotech Makes Multiple Breakthroughs in IIT Clinical Trial for hematological malignancies: 10 Consecutive Patients Achieve Complete Remission

Ichnos Sciences Enters Licensing Agreement For OX40 Antagonist Monoclonal Antibody Portfolio With Astria Therapeutics

Biped, PeriVision and Testmate prepares US market entry with Venture Leaders Medtech program

Purple Biotech Reports Positive Interim and Preliminary Results from NT219 Phase 1/2 Study in R/M Head & Neck Cancer

Three innovators selected for Biopôle’s Start-up Fund

Eco-anxiety: a podcast amplifying the voices of those who are taking action for tomorrow

MediCrops acquires Swiss Alpinopharma

Atinary Technologies raises $5m seed round to turbocharge materials discovery with its machine learning platform

Biped, le copilote intelligent pour les piétons en situation de handicap visuel, remporte le Prix de la Canne blanche 2023

Novostia: Announcement Agreement for FIH

Six Biopôle Members ranking in the Top100 Swiss Startup Award including Haya Therapeutics as Top winner

Epiterna raised €10 Million to help everyone live longer and better

PhenomX Health launches first symptoms and nutrient intake app for menopausal care in Switzerland

PeriVision Achieves Successful Closing of 1st Seed Round Tranche, Revolutionizing Eye Testing & Care

Leman Biotech and Nanjing KATI Sign Comprehensive Strategic Cooperation Agreement to Empower Research and Development of Novel CAR-T Against Solid Tumors

Biopôle Start-up Fund: Latest recipients announced

Novigenix Reports Interim European Validation Data on its New NGS-based Whole Blood RNA Signature for detection of Advanced Colorectal Adenomas

Agreement signed: Novartis collaborates with Biopôle SA

Raphaël Conz joins Biopôle SA’s Board of Directors

PeriVision showcases its novel glaucoma diagnostic system at the World Glaucoma Congress in Rome.

Leman Biotech and Xiangxue Life Sciences Form Strategic Collaboration to Develop Metabolically Enhanced TCR-T Therapy for Solid Tumors

Three Biopôle members win the de Vigier Award 2023

Leman Biotech’s Novel CD19 CAR-T Shows Great Promise in Low-Dose Treatment of Patients with Recurrent or Refractory Lymphoma

Our Corporate Partnership programme grows with Roche Pharma Switzerland

FDA grants Qualified Infectious Disease Product (QIDP) and Fast-Track Designations for Combioxin’s CAL02

The Swiss Medtech Award 2023 goes to Abionic

Terumo Interventional Systems: our new corporate partner

Phase II IIT Study combining Cellestia’s CB-103 and Venetoclax for the treatment of rr/r-T-ALL patients is starting at MDACC

Adaptyv Bio Receives FIT Tech Seed Loan of CHF 100’000

PhenomX Health collaborates with OneDoc on Menopause education

Martin Dewhurst joins the Distalmotion Board of Directors

Consulto wins the FIF Grant from FONGIT

NewBiologix Launches with $50M to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies

Biopôle Start-up Fund: First companies of 2023 announced

Novostia announce new fundraising and opportunity for a new investment round to come

Limula SA receives CHF 2.5 million in non-dilutive funding to accelerate the industrialisation of a closed, automated, and modular solution for Cell and Gene Therapy manufacturing

Purple Biotech Debuts Scientific Advisory Board

ADM Licenses Gnubiotics AMOBIOME for Global Use in Pet Food and Supplement Formulas

PhenomX Health joins the Vanguard Accelerator

Distalmotion raises $150M to accelerate FDA approval and clinical experience

George Coukos distingué par l’American Association for Cancer (AACR)

PeriVision receives CHF 100’000 FIT Tech Seed loans

CSL Behring to open an office on the Biopôle campus

Volv Global SA involved in the programme ‘Together Caring for Rare Disease’

Happy birthday StartLab!

AKYmed is selected as a finalist among 47 challengers for the NewTechAqua Award Challenge

Medicrops receives Swissmedic’s operation licence

Ichnos Sciences Receives Orphan Drug Designation for First-In-Class Bispecific (CD38 x CD47) Antibody Innate Cell Modulator, ISB 1442

CHF 500,000 to boost Alithea Genomics RNA sequencing

Purple Biotech Reports Biomarker Data from CM24 Phase 1 Dose Escalation Study

Thirteen high-growth companies join Scale Up Vaud in 2023

Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of Cancer

Molecular Devices partners with SEED Biosciences to offer DispenCell Single-Cell Dispenser, expanding leadership in cell line development

28 new companies joined Biopôle in 2022

Purple Biotech Reports Fourth Quarter and Full-Year 2022 Financial Results

Limula Partners with CSEM to MAKe PERSONALIZED CANCER THERAPIES ACCESSIBLE TO ALL

CONSULTO.CH GETS SUPPORT FROM FIT

The final three Biopôle Start-up Fund winners of 2022: Volumina Medical, Parithera and PeriVision

ASPIVIX RECEIVES U.S. FDA 510(K) CLEARANCE FOR CAREVIX™, ITS NOVEL CERVICAL STABILIZER

Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of Cancer

Legacy Healthcare joins the second edition of Innovaud’s LeadiNNg to Scale-Up program

LES START-UPS VAUDOISES ONT LEVÉ CHF 548,6 MILLIONS EN 2022, RECORD DU NOMBRE DE RACHATS (OU EXITS)

Incepto entre dans un partenariat stratégique avec les hôpitaux de Marseille (AP-HM)

First patient in a phase III head and neck squamous cell carcinoma study

Atinary Technologies announces collaboration with Parithera

Ludwig Cancer Research, EPFL, CHUV and Roche collaboration leads to major breakthrough in cancer research

GetSet Surgical SA receives Innosuisse Certificate

CARA s’associe à Open Web Technology et lance le Plan de Soins Partagé

Alithea Genomics and partners to develop a first-of-a-kind pan-cancer blood test

Legacy Healthcare Announces Positive Top-Line Results from Phase 2/3 Trial of Coacillium cutaneous solution, the first drug for children and adolescents with Moderate and Severe Alopecia Areata

Purple Biotech and Mor Research Applications Announce Research Collaboration to Identify Promising Investigational Oncology Treatments

Biped.ai is partnering with Honda Research Institute Europe GmbH

Distalmotion announces new appointments to the leadership team

PeriVision selected for NHS glaucoma monitoring study

Medistri to Welcome its Fifth Sterilization Line

Ichnos Sciences Data Selected for Presentation at the 64th ASH Annual Meeting

New investment of 1 million into Novostia

Consulto: The Vanguard Accelerator’s latest start-up

First successful transplantation for Vanarix

Limula launches its pilot phase

GetSet Surgical announce first in patient surgeries

A FIT Tech Growth Loan for Volumina Medical

David Neale CEO of Argá Medtech recognised as one of the 30 innovators to watch in 2022 according to The Silicon Review.

Opna Bio Launches with $38 Million Series A Financing to Advance Novel Oncology Discovery Program and Diversified Pipeline of Clinical and Preclinical Programs

Genknowme and SEED Biosciences selected in the 2022 cohort of the Scaling Up Sales programme

Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis

Novigenix announces first closing of its $20M Series B

Purple Biotech Appoints Lior Fhima as Chief Financial Officer

Vivactis Switzerland launches a series of free webinars on marketing for life sciences ventures

Argá Medtech Initiates First in Human study

Argá Medtech selected as TOP 10 Medtech Start-ups in Europe

Abionic Webinar report: Guiding Clinical Care Using Pancreatic Stone Protein, chaired by Professor Jean-Louis Vincent

Resilient concluded an Innocheque Project with SUPSI

PeriVision receives CHF 1.6M R&D grant for remote patient monitoring

RadioMedix announces a $40 million Series A financing

Tigen exercises first option from the T Cell Program at the CHUV on behalf of the Ludwig Institute for Cancer Research for the development of a Neoantigen-specific Tumor Infiltrating Lymphocytes product (NeoTIL)

New Biopôle Start-up Fund winners: ND Biosciences and Limula

VOLUMINA MEDICAL closes its Series A funding to further develop its lead product AdipearlTM

Biopôle to sustain its growth with further investment from Edmond de Rothschild Real Estate SICAV

Ichnos Sciences Announces Initiation Of First-In-Human Study For ISB 1442

Biped.ai and Genknowme selected for the Future of Health Grant program

Hedera Dx raises €14 million in seed funding to accelerate global adoption of liquid biopsies

Incepto, spécialiste de la santé digitale, lève 27 millions d’euros

SEED Biosciences’ DISPENCELL is approved for use in cleanrooms and sterile environments

2022 TOP100 Start-ups Award: Four Biopôle based start-ups and one scale-up awarded in Schlieren

Testmate Health SA, alongside a consortium of R&D partners are awarded a €1,37 million non-dilutive grant through the Eurostars Programme

PDC Therapeutics Announces Dose Escalation in the Phase I Clinical Study of RS-0139

PeriVision presents AI research at IPS conference in Berkeley

Argá Medtech SA to present at LSI Emerging Medtech Summit 2022

AC BioScience closes fourth Seed Round for CHF 2.5M

Perivision joins the Vanguard Accelerator

Vanarix is one of the ten innovative startups selected for Venture Leaders Biotech 2022

University Hospital Tübingen carries out first Dexter® surgeries in Germany

ADC Therapeutics inks multi-million licensing deal with Sobi

Biopôle member Ichnos Sciences becomes our newest corporate partner

Volv workshop at WODC: creating a better clinical development strategy for rare diseases through AI innovation

A case study shows contribution of Cellestia ’s CB-103 in achieving complete response in a relapse/refractor T-ALL patient

Argá Medtech SA Featured in Medtech Strategist

Biped.ai selected for the Biopôle Start-up Fund’s next round

Gnubiotics Sciences and the University of Pennsylvania to Explore CAR-T Therapy in Combination with Glycopeptides Targeted to Solid Tumors

Limula wins prestigious EIC grant of 4.7 million euros to develop its disruptive technology with European partners

Hôpital de La Tour is the latest sponsoring partner of Biopôle’s Digital Health Hub

Gnubiotics to Present Data at the Annual Meeting of the American Society of Clinical Oncology (ASCO) 2022

Alithea Genomics Raises CHF 1 Million in Seed Financing Round led by Novalis Biotech

Argá Medtech SA presents CSE @ HRS2022

Purple Biotech Announces the Initiation of Phase 2 Study for CM24 in 2L PDAC Patients

Ichnos Sciences Announces Selection of Trispecific Antibody ISB 2001 as Next Clinical Candidate for Relapsed/Refractory Multiple Myeloma

Gnubiotics Announces Microbiome Innovation Strategic Partnership With ADM 

PeriVision patent claims accepted by US Patent & Trademark office

Swiss Start-ups Limula and Ceidos Receive Highly Competitive Eurostars Grant of over EUR 1 million to Partner with Portuguese CDMO Stemmatters and Augment Modular Cell Therapy Manufacturing Platform

Genknowme launches a new digital platform to improve customer experience and reenforce data protection

Innovaud poursuit avec succès sa mission auprès de l’économie vaudoise

AC BioScience has been awarded gold status by the EIT Health Investor Network

Volumina Medical wins the Clinique La Prairie Innovation Award

Gnubiotics Sciences SA to present at the 2022 American Association for Cancer Research (AACR) Annual Meeting

Alithea Genomics and AdipoGen Life Sciences announce partnership

Saintonge becomes first hospital in France to install the Dexter® surgical robot

Cellestia One of the Fourteen Swiss Startups ready for Scaling

Genknowme’s Biological Age Patent is filed

Novigenix and Philips Sign Technology License Agreement for Prostate Cancer Precision Oncology Products

Scale Up Vaud attracts record number of new scale-ups and investment

A FIT TECH GROWTH LOAN OF CHF 400’000 FOR SEED BIOSCIENCES AND THE DISPENCELL TECHNOLOGY

AC BioScience obtains Eurostars grant

Découverte prometteuse dans le traitement de la dystrophie musculaire de Duchenne

Biopôle Start-up Fund: Testmate Health and Atinary Technologies are nominated

Limula receives a FIT Tech Seed loan of CHF 100’000

CHF2.5 million to build up the most powerful protein engineering platform

SEED Biosciences wins the New Product Award at SLAS2022

HAYA Therapeutics Establishes U.S. Location

abc biopply and SEED Biosciences collaborate on the automated individualization of highly homogenous and uniform spheroids

Sensemodi wins CHF 150,000 to assess joint health with an innovative wearable

AC BioScience appoints Peter Hug, Ph.D., to the Board of Directors

Le financement des start-ups vaudoises a battu un record en 2021 en dépassant CHF 1 milliard

Distalmotion raises $90M to accelerate adoption of surgical robot Dexter

ADC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize ZYNLONTA® (loncastuximab tesirine-lpyl) in Japan

SIB presents new resources in their infrastructure portfolio for the life sciences

Ichnos Sciences and Almirall Enter Into a Licensing Agreement for First-In-Class IL-1RAP Antagonist Monoclonal Antibody

Cellestia Biotech announces that the European Commission has granted CB-103 an orphan designation for the treatment of Acute Lymphoblastic Leukaemia (ALL).

Adaptyv Biosystems and Alithea Genomics level up with support from Biopôle’s Start-up Fund

Developing the science of nutritional status: the mission of the new Swiss Nutrition and Health Foundation, formerly the Swiss Vitamin Institute Foundation

Centre André Henzelin offers naturopathic consultations

Ichnos Sciences Presents Preclinical Data On Novel ISB 1442 In Relapsed/Refractory Multiple Myeloma At The ASH 2021 Annual Meeting

Biopôle SA expands its partnership programme with Swiss Medical Network

Abionic launches ultra-fast on site COVID-19 Saliva Test aimed at schools, hotels, airports and restaurants

Keynote at the BioData World Congress by Genomsys’ Chief Technology Officer Claudio Alberti

Resilient AG and SUPSI run a cross-sectional study under the Innocheque umbrella with promising initial results.

Atinary Technologies launched collaboration with IBM Research Europe

ND BIOSCIENCES AWARDED A GRANT FROM THE MICHAEL J. FOX FOUNDATION

A new podcast on mental health by RADAR RP

Online Dermatology

Testmate Health has successfully closed an oversubscribed seed round of 1.62 million CHF

Biopôle launches new collaboration with Bristol Myers Squibb

ND BioSciences Announces partnership with The Michael J. Fox Foundation for Parkinson’s Research to make available alpha-synuclein oligomers to the scientific community

Foundation of the RE(ACT) Discovery Institute

Opening of exclusive higher education course at the Centre André Henzelin (cAH): Neuro-Functional Programming Therapy

Gondola Medical Technologies and the renowned Mount Sinai Health System enter research collaboration

Biopôle SA Partners With Labcorp to Help Drive Scientific, Technological Innovation

GenomSys and Philips join forces for novel genomic analysis solutions

Biopôle Start-up Fund: Novostia and Genknowme are the first start-ups nominated

Novigenix Announces Election of Dr. Miro Venturi to its Board of Directors

ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million

Radar PR organises the Neuroscience Summit in Crans-Montana [FR]

Eagle Pharmaceuticals Announces Worldwide Licensing Agreement with Combioxin SA for Phase 2b/3, Novel First-in-Class Antitoxin Agent CAL02 in Development for Combination Use with Antibiotics for the Treatment of Severe Pneumonia

SEED Biosciences obtains the electronic compatibility certification for DISPENCELL

Combioxin SA has moved to the Biopôle in Epalinges, Switzerland

Cellestia Biotech receives investment to advance first-in-class therapies to control and modulate pathogenic gene expression

Les Vaudois ont désormais accès au dossier électronique du patient

Novigenix Wins the 2021 Felix Burda Award in Medicine & Science

Pioneering Hybrid Robotics in General Surgery at the CHUV

Superlab invente l’hôtel biotechnologique

Gnubiotics Sciences at Venture Leaders Biotech 2021

Gnubiotics Announces Self-Affirmed GRAS Designation of GNUbiome FI

The world first hybrid Robotic surgery took place at the Insel Spital in Bern

AMBITION: A clinical study focusing on “Freezing of Gait” (FOG)

AC BioScience: Committed to Fight Against Cancer

HAYA amongst the “Top 15 Swiss Biotech Startups Making a Difference in Europe”

Le petit robot suisse qui veut conquérir l’Amérique

CARA lance le dossier électronique du patient en Suisse occidentale

Le Biopôle est en pleine santé

Germany meets Hybrid Robotics – Germany meets Dexter

Gnubiotics has gained allowance from the European Patent Office (EPO) for patent application of our microbiome markers for prediction, identification and treatment of pet obesity

HAYA Therapeutics Completes CHF 18 Million Seed Financing to Advance Anti-fibrotic Therapies Targeting Long Non-Coding RNAs

Biopôle SA Unveils its New Start-up Fund to Foster Early Innovation in the Life Sciences

Prof. Rana Sanyal named Cartier Women’s Initiative 2021 Science & Technology Fellow

Opening of Rachis Clinic at Biopôle

ADC Therapeutics Announces FDA Approval of ZYNLONTA™ (loncastuximab tesirine-lpyl) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Novostia presents outstanding animal study results

GenomSys successfully CE marks its MPEG-G Codec Suite

Ferring Biologics Innovation Centre opens at Biopôle

Gabi SmartCare just raised 3 million euros to transform pediatric care

CHF 500k to boost Gondola’s Clinical Research Momentum

Clinique La Prairie, a leader in anti-aging medicine, selects Genknowme for its epigenetic testing

Novigenix Appoints Mr. Valentin Matillon as President and Chief Business Officer

Milk prebiotics for pet food

GenomSys opens new branch in Lugano

Lana Kandalaft’s team new study: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer

Cellestia – a leading pioneer in modulating gene expression has received the Innosuisse Certificate

GenomSys welcomes new Chief Scientific Officer Luca Trotta

Lausanne University Hospital ranked among the ten best hospitals worldwide

Biopôle SA will host the first branch of Superlab Suisse

Scailyte and Volv Global Announce Strategic Partnership to Accelerate Rare Disease Patient Diagnosis

7 new companies join the Scale Up Vaud program

Diaclone and SEED Biosciences collaborate on the development of a new workflow for rapid antibody discovery

Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy

Onward Therapeutics and Biomunex Pharmaceuticals Enter into a Worldwide Exclusive License and Co-development Agreement to a Bispecific Antibody for Immuno-Oncology

Biopôle SA poursuit son expansion avec la construction de trois nouveaux bâtiments dédiés aux sciences de la vie

2.1 billion for Swiss startups Investment in Vaud based startups reach CHF 409.1 million; record number of financing rounds in our canton since 2012.

New Digital Health project with the CHUV at the Biopôle

ND Biosciences’ founders publish a systematic and critical review of Parkinson’s disease models in Nature Reviews Neuroscience, and suggest new approaches to advance disease modelling and drug discovery for neurodegenerative diseases.

Unisanté and Genknowme join forces to explore the impacts of lifestyle on epigenetics

Novigenix-Led Consortium Secures Eurostars Funding to Develop Predictive Immune Checkpoint Inhibitor Test

Distalmotion Receives European CE Mark for Dexter Surgical Robot

AC BioScience announces a License Agreement with Lexicon Pharmaceuticals Ltd. and closes third Seed Round for CHF 0.8 million

2020 at Biopôle: The year in review

Top 10 Biopôle-based companies by capital raised in 2020

11 companies joined Biopôle in 2020

Cellestia Biotech launches new drug discovery program to target Transcription Factors

Telemedicine communication and data transfers simplified by Pryv & Dreamix: OEM modular communication tool for clinics, software and hardware healthcare providers

CSL BEHRING REI TEAM AND BIOPÔLE ENTER A COLLABORATION PARTNERSHIP

Ichnos November 2020 update

Facilitim to service the Serine Building!

resilient received the Seal of Excellence from the European Commission and opens its Seed Round

Abionic launches first Covid-19 severity test to triage patients quickly and accurately

GONDOLA – 365 days in retrospect

Un million pour le robot de pipetage de Seed Biosciences

ADC Therapeutics Announces FDA Accepts Biologics License Application and Grants Priority Review for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

A first partnership with the Swiss Center for Preventive Medicine for the epigenetic profile of Genknowme

Mymetics to advance Preclinical Studies for Virosome-based Covid-19 Vaccine through Innosuisse grant

Ofac Group, the Swiss Pharmacy Cooperative Corporation, launches Abilis 2.0

Ludwig Lausanne receives Team Science Award from the Society for Immunotherapy of Cancer

ADC Therapeutics Announces Eight Presentations on Data from its Next-Generation Antibody Drug Conjugates at the 62nd American Society of Hematology Annual Meeting

UNILABS TO OPEN FOUR DEDICATED COVID-19 TEST SITES IN SWITZERLAND

HeartKinetics, the daily home cardiac monitoring solution, chose Pryv.io privacy middleware to manage patients data and consent, rightfully.

Nouria Hernandez rapprochera le Biopôle des hautes écoles

Pryv and CYSEC launch an integrated solution for collection and confidential computing of personal data at scale

Novigenix presents new Immuno-Transcriptomic data for prediction of response to immunotherapy in metastatic urothelial cancer patients

Our latest machines won’t change the world

Aquatis: quand l’IMD s’en mèle…

A new approach to surgical robotics for minimally invasive care

The vaccine formulation institute (VFI) joins the Biopôle

Vivactis Goup will be broadcasting the European association for cardio-thoracic surgery

GenomSys welcomes Alessio Ascari as new Chief Executive Officer

The EPFL spin-off ND BioSciences receives CHF 100’000 to fight neurodegenerative diseases

Gnubiotics Sciences SA announces a CHF 2.6 million Series A1 fundraise

Anergis and Virometix Announce Research Collaboration to Use Synthetic Virus-Like Particles for Ultra-Fast Allergy Immunotherapy

Biopôle to Gain a New Building Dedicated to Life Sciences

Pryv SA releases an Open-Source Solution for Personal Data & Privacy Management

Mymetics Reports Successful Preclinical Study Results with COPVirosomes as Second-Generation Allergy Immunotherapy

AC BioScience closes second Seed Round for CHF 1 million

ADC THERAPEUTICS ANNOUNCES CLOSING OF UPSIZED $267 MILLION INITIAL PUBLIC OFFERING AND RECEIPT OF THE $65 MILLION FIRST TRANCHE UNDER ITS $115 MILLION CONVERTIBLE CREDIT FACILITY WITH DEERFIELD

Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines

ADC THERAPEUTICS ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERING

Build38 and Pryv Team Up to Simplify Mobile Security and Privacy for Digital Health Companies

ADC Therapeutics: $115 MILLION CONVERTIBLE CREDIT FACILITY WITH DEERFIELD

Biomapas Opens a New Office in Kazakhstan

Biopôle is proud ambassador of DIGI-B-CUBE

Innovation as a Culture

Gnubiotics accelerates testing of multivalent-glycan based pipeline candidates against viral entry of COVID-19

Dexter successful validation brings Distalmotion surgical robot one-step closer to commercialization

Biomapas appoints Chief Business Officer

Interview with ND-BioSciences

CHF 150,000.- for epigenetic testing and plant-based meat startups

Medisanté and Pryv Collaborate to Simplify Remote Patient Monitoring and Guarantee Privacy-by-Design

Innovation Programmes @ Biopôle

Biomapas strengthens its footprint in Poland in the run-up to its further growth in Central Europe

10 years of Biopôle by Nasri Nahas

Data published in npj Vaccines show Mymetics’ malaria CyRPA virosome vaccine elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models

MEDEUROPA COMPLETES FIRST FRENCH INVESTMENT, JOINING FORCES WITH THE CENTRE CATALAN D’ONCOLOGIE OF PERPIGNAN

Novigenix-Led Consortium Secures Eurostars Funding to Develop Multi-Omics Test for Colon Cancer Detection and Monitoring

Swiss AI startup Deep Cube breaks World Record

25 new life sciences companies joined Biopôle community in 2019

DEEP CUBE BREAKS WORLD RECORD FOR LARGEST GOLDEN RATIO CALCULATED (20,000 BILLION DIGITS AFTER THE VIRGULA) USING THE HPE APOLLO 6500 SYSTEM

ADC Therapeutics Appoints Joseph Camardo, MD, as Head of Medical Affairs

Abionic integrates first patients in US clinical trial for sepsis diagnosis method

ADC Therapeutics Announces Positive Results from Pivotal Phase 2 Clinical Trial of Single Agent Loncastuximab Tesirine (ADCT-402) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

A new pond for protected birds completed in 2019

Cellestia Biotech lève encore 20 millions de francs

Resistell AG closes CHF 3.5M series A financing round

ADC Therapeutics Announces Oral Presentation of Interim Efficacy Data from Pivotal Phase 2 Clinical Trial of ADCT-402 (Loncastuximab Tesirine) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma at 61st ASH Annual Meeting

GNUbiotics Sciences announces a strategic agreement with Evonik Nutrition & Care to manufacture GNUbiotics’ Animal Milk Oligosaccharide, AMObiome™

ADC Therapeutics Announces Publication of ADCT-402 Data in Clinical Cancer Research

BioAlps Networking Day 2019 | 29 octobre | Théâtre du Crochetan | Monthey (VS)

BIOALPS NETWORKING DAY 2019

Fast progress for Novigenix

ADC THERAPEUTICS DOSES FIRST PATIENTS IN PIVOTAL PHASE 2 CLINICAL TRIAL OF ADCT-301 IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA

Stallergenes Greer and Anergis Initiate New Study to Predict Efficacy of Second-Generation Allergen Immunotherapy

ICHNOS SCIENCES LAUNCHES AS NEW, INDEPENDENT, LEADING-EDGE BIOTECH DEDICATED TO OUTPACING DISEASE

Gondola MedTech completes funding round, eyes to enter the US Market

Novigenix and Radiomedix to Develop Neuroendocrine Cancer Precision Diagnostic Test

GEW Switzerland: Raising more Awareness for Entrepreneurship

StartLab among the 20 Best Biotech Incubators Hatching Startup Stars in Europe

Abionic is now certified Great Place to Work

ND-BioSciences awarded a grant from The Michael J. Fox Foundation to help advance the foundation’s α-Synuclein biomarkers discovery and validation programs

Novigenix progresse sur un nouveau test sanguin

CHF 100’000 FOR HAYA THERAPEUTICS

ADC Therapeutics recognized with Excellence Award at Convergence in Oncology Summit

Abionic: International Pivotal Study Successfully Demonstrates Diagnosis of Sepsis within 5 Minutes – 24 Hours Earlier Compared with Current Standard-of-Care

Success story: Lana Kandalaft, the personal vaccinologist

Clinerion partners with Volv Global to bring treatment earlier to patients by enhancing diagnosis search on Patient Network Explorer with inTrigue AI algorithms.

Novigenix to Present Data on New Molecular Signature for Early Detection of Colon Cancer at ESMO 2019

ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering

Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests

Swiss AI startup Deep Cube shines in Shanghai

ADC Therapeutics and Freenome Enter Biomarker Development Collaboration

ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial

“In five years there will be five tech hubs in Europe that matter, and Lausanne will be one of them”

ADC Therapeutics Announces Final Close of Series E Financing Expansion

DEEP CUBE Received CES Asia 2019 Awards at SWISSTECH Pitching Night

ADC THERAPEUTICS ANNOUNCES COMPLETION OF A SERIES E FINANCING EXPANSION

MOLECULAR CHATTER MAKES FOR A “HOT TUMOR”

Thierry Weber: «La pratique de la médecine va vivre une révolution»

Instant T : Petite cellule mais grande invention

Novigenix Developing NGS Version of Early Colorectal Cancer Detection Test

Novigenix Appoints Dr. Jan Groen as CEO to Lead Expansion to Multi-Product Cancer Diagnostic Platform Company

Mymetics Receives Funding from NIH for Novel HIV Vaccine Study

ADC Therapeutics and Adagene Announce License Agreement

Sun bioscience standardise la culture de tissus humains

Gnubiotics est aux petits soins envers les intestins

Volumina Medical régénère la chair

Seed Biosciences teste sa solution unicellulaire abordable

Le StartLab célèbre son premier anniversaire

Haya Therapeutics, aux racines de l’insuffisance cardiaque

A spin-off’s injectable implant takes top honors at Seed Night

SFL publishes impact assessment article in European Pharmaceutical Law Review

Swiss biotech Gnubiotics, announces global launch of GNU100 the first microbiome specialty ingredient for companion animal gut health.

Le dîner du futur se partage bientôt à Vevey

Lyonbiopôle et Biopôle SA s’allient avec Nestlé Health Science pour stimuler l’innovation entre entreprises dans le domaine de la nutrition santé

Newsweek magazine ranks the CHUV as one of the world’s ten best hospitals

Biopôle launches the Digital Health Hub

Sylke Hoenel, Co-Founder and CEO at SUN Bioscience selected among the 2019 finalists of the Cartier Women’Initiative

Biowatch, l’authentification en continu au poignet

SenSwiss wins the Biopôle StartLab Prize at the Swiss Finals of the Global Accelerator Imagine IF organised by Innovation Forum Lausanne

Seed Biosciences and Andrew Alliance receive innovation awards in Washington

New restaurant on campus: CSS’s Ven’art Restaurant is open to the public since January 1st, 2019

SUN Bioscience selected for StartLab Incubator

BioAlps moves main office to Biopôle

Catalyze: a new corporate special offer dedicated to Biopôle members

New application deadline Startlab: 31 March 2019

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors

ADC Therapeutics to Appoint Peter Hug, Ph.D., to Board of Directors

Anergis Reports Positive Preclinical Proof-of Concept Data of the Second-Generation COP Allergy

Mymetics Virosomes Successful in Allergy Proof-of-Concept Study

GNUBiotics Sciences won Startup Innovation Challenge – Ingredients Category at HiE 2018

Un nouveau biotope pour les bécassines sourdes

Biopôle Lausanne: the campus where immunology scales up

SEED Biosciences joins three talented ventures at StartLab

AIMMUNE THERAPEUTICS ANNOUNCES ADDITIONAL EQUITY INVESTMENT BY NESTLÉ HEALTH SCIENCE

Biopôle life sciences campus continues to expand with the construction of a new building

Le sommet d’oncologie révèle un tournant

Mymetics Starts Research Collaboration Project in Cancer Immunotherapy with eTheRNA

CINQ ANS D’INNOVATION DANS LE CANTON DE VAUD !

Glenmark Pharmaceuticals S.A. Opens New Translational Discovery Centre at Biopôle Lausanne-Epalinges

Collaboration ISV & Champidor

Anergis Initiates Development of Second-Generation COP Allergy Vaccines; Announces Publication of Sustained Efficacy Data from Ph. IIb Study Follow-up

A promising first Convergence in Oncology Summit

Mymetics : Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability

Romandie medtech and biotech shine in Venture Kick finale

ADC Therapeutics Doses First Patient in Pivotal Clinical Trial of ADCT-402 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Legacy Healthcare signs an Investment & Joint-Venture Agreement with China Energy Hua Chen Technology

GNUBiotics Sciences introduces next generation HMOs composed of up to 130 diverse microbiota accessible carbohydrates (MACs) structures

La recherche en sciences de la vie offre un nouvel essor au Biopôle

Retraites Populaires and Biopôle SA unveil the SE-B building and StartLab, the first incubator dedicated to life sciences located in the Canton of Vaud

Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast Allergy Immunotherapy

LUDWIG RESEARCHERS DEVISE AND TEST PIONEERING PERSONALIZED CANCER VACCINE FOR OVARIAN CANCER

Abionic Successfully Raises CHF 20 Million in Series C Financing

Mars Bleu, une campagne pour sensibiliser au dépistage du cancer colorectal soutenue par Novigenix

Ludwig Lausanne – UNIL-CHUV Oncology department study extends the potential for personalized immunotherapy to a large variety of cancers

Glenmark Pharmaceuticals S.A. to Invest in New Translational Research Group at Biopôle Lausanne-Epalinges

Haya Therapeutics passes Venture Kick stage 2

Swiss Venture Capital Report 2018: ADC Therapeutics ranks #1 in top 20 VC rounds in Switzerland for the second consecutive year, closing CHF 197 Million in 2017

Cristalean et Medidee s’associent pour mieux servir l’innovation MedTech en Wallonie

Gnubiotics Sciences raises CHF 2.3 million

Abionic selected as one of the best Medical Technologies of 2017 by Medgadget

NEW INNOTREK GRANT AWARDED TO DANIEL BLESSING

ADC Therapeutics Presents Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-402

Abionic Announces Appointment of Leading Diagnostics Industry Experts to Board of Directors

Nestlé extends consumer healthcare portfolio by agreeing to acquire Atrium Innovations

PACTT CONGRATULATES CHUV MASSCHALLENGE LAUREATES HAYA AND LYMPHATICA

BIOPOLE APPOINTS MEMBERS OF STARTLAB ADVISORY BOARD AND ANNOUNCES FIRST CANDIDATES SELECTED FOR STARTLAB INCUBATOR

Legacy Healthcare raises CHF 2 million

SimplicityBio is Awarded the CTI Start-Up Label

Abionic prouve ses compétences aux Etats-Unis après l’Europe

ADC Therapeutics Announces Closing of $200 Million Private Financing to Fund Two Lead Programs Through Registrational Trials

Abionic Announces FDA Registration for World’s Most Rapid Allergy Test and abioSCOPE® Diagnostic Testing Platform

NESTLÉ HEALTH SCIENCE AND CODEXIS CREATE PARTNERSHIP TO ACCELERATE ENZYME INNOVATION FOR MULTIPLE HEALTH CONDITIONS

SYNAPTIVE MEDICAL UNVEILS NEXT GENERATION OF SURGICAL ROBOTICS WITH GROUNDBREAKING OPTICS PLATFORM

SunRegen Healthcare AG awarded special “StartLab prize” by Biopôle at the IMAGINE IF! Accelerator for Science Ventures Swiss finals

LUDWIG SCIENTISTS DISCOVER COMPLEX AXIS OF IMMUNE SUPPRESSION EXPLOITED BY CANCERS

Anergis Announces Top Line Results From Large-Scale ATIBAR Trial With Ultra-Fast Allergy Immunotherapy AllerT

Ludwig Cancer Research releases its Annual Research Highlights Report 2017

SimplicityBio SA Joins 3.2M Eurostars funded HeartLinc Program

NESTLÉ HEALTH SCIENCE ENTERS THE MICROBIOME DIAGNOSTICS FIELD THROUGH A PARTNERSHIP WITH ENTEROME

Alliance lausannoise pour la recherche en oncologie

Nasri Nahas, CEO of Biopôle, interviewed on the « Swiss Entrepreneurs Foundation », the new startup fund of CHF 500 Mio announced by the Federal Councillor Mr. Schneider-Ammann.

NESTLÉ HEALTH SCIENCE AND THE STROKE FOUNDATION (AUSTRALIA) COLLABORATE TO IMPROVE LIFE AFTER STROKE FOR SURVIVORS

Biopôle announces StartLab, Tailor-made incubator for life science entrepreneurs

World’s fastest Sepsis Test from Abionic Produces Result in Five Minutes when Tested in patients at London and Zurich Hospitals

ADC Therapeutics Doses First Patient in a Phase I Clinical Trial of ADCT-502 in Patients with Advanced Solid Tumors with HER2 Expression

Nestlé Health Science partners with AliHealth for the launch of Boost in China

SimplicityBio: 2017 Red Herring Top 100 Europe Award Finalist

«Les thérapies cellulaires débuteront cet été»

NESTLÉ HEALTH SCIENCE AND CHINESE STROKE ASSOCIATION COLLABORATE TO TACKLE SWALLOWING DIFFICULTY (DYSPHAGIA)

Novigenix Signs Distribution Agreement with Dr Risch Medical Laboratory to Access Swiss German Market for Colox®, its blood based colorectal cancer test

TAmiRNA And SimplicityBio Join Forces To Improve MicroRNA Biomarker Development

Abionic to open distribution channel in the United Kingdom and Ireland

Ludwig Lausanne’s Johanna Joyce won a Cancer Research UK Grand Challenge award

Abionic décroche deux nouvelles reconnaissances : les SEF High Potential & Finance Monthly Game Changers Awards

Anergis Completes Patient Recruitment In Large-Scale ATIBAR Trial With Ultra-Fast Allergy Immunotherapy AllerT

SimplicityBio appoints Matthew Hall as CEO to drive growth

ADC Therapeutics ranks #1 in top 20 VC rounds in Switzerland in 2016 with CHF 104 Million

Anergis Appoints Klaus Schollmeier As New Chairman Of The Board Of Directors

A new director for the IUMSP in 2017

Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA® (pembrolizumab)

Abionic Receives CE Mark for Most Rapid Sepsis and Iron Deficiency Point of Care Diagnostics

Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease

CHMP Recommends Approval of Lilly’s Baricitinib for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis (RA)

MYMETICS STARTS RESEARCH PROJECT WITH SANOFI FOR INFLUENZA VACCINES

NESTLÉ HEALTH SCIENCE INVESTS IN AIMMUNE THERAPEUTICS, CREATING A STRATEGIC COLLABORATION TO DEVELOP DESENSITIZATION THERAPIES ACROSS MULTIPLE FOOD ALLERGIES

TATAA Biocenter and SimplicityBio Announce Complete Solution for Biomarker Discovery, Signature Optimization and Validation

ADC Therapeutics Announces Closing of $105 Million Private Financing

New building at Biopôle to welcome more life science organisations from 2018

300 chercheurs sous un même toit

NESTLÉ HEALTH SCIENCE EXPANDS ITS DYSPHAGIA OFFERING

Ludwig Cancer Research releases its Annual Research Highlights Report

Nestlé Health Science Launches MyTubeFeedingKid.com to Support Pediatric Tube-Feeding Journey

Lausanne: Biopôle se réorganise pour la gagne!

BIOPOLE ANNOUNCES NEW BOARD OF DIRECTORS AS KEY STEP IN RE-POSITIONING OF LEADING SWISS LIFE SCIENCES COMMUNITY

Incyte and ARIAD Announce Agreement for Incyte to Acquire ARIAD’s European Operations and In-license Iclusig® (ponatinib) in Europe

Novigenix publishes multi-center study of Colox® in Clinical Cancer Research

Mymetics announces successful preclinical results with malaria transmission-blocking vaccine candidate

Anergis Closes CHF 5 Million Financing Round Extension to Conduct the ATIBAR Trial

ADC Therapeutics lève $ 80 millions

Nasri Nahas nommé à la direction de Biopôle S.A.

L’Institut Ludwig va s’installer au Biopôle

Inauguration de la permanence Mobilité

Nouveau financement de CHF 14.5 millions pour Anergis

Le Conseil d’administration se renforce

Ariad inaugure ses locaux au Biopôle

Visite d’une délégation Guangzhou Chine

Deux sociétés du Biopôle parmi les 50 start-up helvétiques dans lesquelles investir

ARIAD PHARMACEUTICALS s’installera au Biopôle

Société Biopôle : désignation des cinq membres du Conseil d’administration

Biopôle de Vennes : l’Etat cède des terrains et octroie une servitude de superficie à Métro-Lausanne-Ouchy SA

Un site pour accueillir les start-ups du domaine de la biotechnologie